★ WIDE MOAT STOCKS & COMPETITIVE ADVANTAGES ★
VOL. XCIV, NO. 247
Stock Profile
Zimmer Biomet Holdings, Inc. (ZBH) Moat Analysis
Zimmer Biomet Holdings, Inc.
ZBH · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Request update
Spot something outdated? Send a quick note and source so we can refresh this profile.
Overview
Zimmer Biomet is a global orthopedic medical-device company focused on knee and hip reconstruction, plus sports medicine, extremities, trauma and robotics/digital products. Its moat is primarily surgeon- and workflow-based: local sales and clinical support, consignment-heavy logistics, and procedural familiarity with implant systems and instruments. Q1 2026 revenue was led by Knees (~40%), S.E.T. (~27%), and Hips (~25%). The latest directly attributable category-share evidence retained here is the 2023 ORTHOWORLD dataset, which showed Zimmer Biomet leading worldwide knee and hip implants; no newer exact category split was verified.
Primary segment
Knees
Market structure
Oligopoly
Market share
30.1% (reported)
HHI: —
Coverage
4 segments · 5 tags
Updated 2026-07-12
Segments
Knees
Knee reconstruction implants (primary, partial, revision) plus associated instruments and orthopedic robotics/navigation
Revenue
39.7%
Structure
Oligopoly
Pricing
moderate
Share
30.1% (reported)
Peers
Hips
Hip reconstruction implants (primary and revision) plus associated instruments and orthopedic robotics/navigation
Revenue
25.1%
Structure
Oligopoly
Pricing
moderate
Share
23.5% (reported)
Peers
S.E.T. (Sports Medicine, Extremities, Trauma, CMFT)
Sports medicine, extremities, trauma, biologics and CMFT orthopedic devices
Revenue
26.9%
Structure
Competitive
Pricing
weak
Share
—
Peers
Technology & Data, Bone Cement and Surgical
Orthopedic surgical robotics and navigation, digital care pathways/analytics, bone cement, and surgical instruments
Revenue
8.2%
Structure
Oligopoly
Pricing
moderate
Share
—
Peers
Moat Claims
Knees
Knee reconstruction implants (primary, partial, revision) plus associated instruments and orthopedic robotics/navigation
Revenue share computed from Q1 2026 Form 10-Q product-category table: Knees net sales $828.6M / $2.087B total.
Design In Qualification
Demand
Design In Qualification
Strength
Durability
Confidence
Evidence
Knee systems are embedded in surgeon preference and OR workflow; adoption requires system-specific training and familiarity (instrument sets, technique, rep support).
Design In Qualification moat: definition, examples, and stocks
Erosion risks
- Hospital standardization reduces surgeon choice
- New implant designs narrow differentiation
- Shift of volume to price-sensitive ambulatory surgery centers
Leading indicators
- Knee share trend vs SYK/JNJ/SNN
- Pricing realization (net price/mix)
- Adoption rates of new knee platforms and robotics-assisted procedures
Counterarguments
- Surgeons can switch with retraining; competitors also run extensive education programs
- Hospitals can force standardization via tenders and bundled purchasing
Service Field Network
Supply
Service Field Network
Strength
Durability
Confidence
Evidence
Dense field support and consignment-heavy logistics improve case coverage and service reliability at the facility level.
Service Field Network moat: definition, examples, and stocks
Erosion risks
- Distributor/channel disruption
- ERP/logistics execution issues
- Hospital consolidation reduces the value of local density
Leading indicators
- Backorder/fill-rate metrics
- Rep productivity and churn
- Customer complaint / service levels
Counterarguments
- Large competitors have comparable field organizations and consignment models
- Health systems may centralize inventory and reduce vendor footprint
Hips
Hip reconstruction implants (primary and revision) plus associated instruments and orthopedic robotics/navigation
Revenue share computed from Q1 2026 Form 10-Q product-category table: Hips net sales $524.1M / $2.087B total.
Design In Qualification
Demand
Design In Qualification
Strength
Durability
Confidence
Evidence
Hip systems are procedure-embedded; surgeon familiarity and instrument ecosystems create meaningful switching/qualification costs.
Design In Qualification moat: definition, examples, and stocks
Erosion risks
- Commoditization of stems/cups
- Purchaser-driven standardization and tendering
Leading indicators
- Hip share trend vs SYK/JNJ/SNN
- Revision mix and outcomes data publications
Counterarguments
- Competitors offer comparable implant platforms and education programs
Service Field Network
Supply
Service Field Network
Strength
Durability
Confidence
Evidence
Local field coverage and consigned inventory support case readiness and responsiveness at the account level.
Service Field Network moat: definition, examples, and stocks
Erosion risks
- Distributor instability in certain regions
- Execution issues that reduce service levels
Leading indicators
- Order fill rates and backorders
- Regional growth vs market
Counterarguments
- Incumbent peers also operate large field organizations
S.E.T. (Sports Medicine, Extremities, Trauma, CMFT)
Sports medicine, extremities, trauma, biologics and CMFT orthopedic devices
Revenue share computed from Q1 2026 Form 10-Q product-category table: S.E.T. net sales $562.2M / $2.087B total.
Service Field Network
Supply
Service Field Network
Strength
Durability
Confidence
Evidence
Field support and medical education help drive adoption and utilization across procedure types.
Service Field Network moat: definition, examples, and stocks
Erosion risks
- Distributor turnover in smaller markets
- Margin pressure reduces ability to fund field headcount
Leading indicators
- Salesforce productivity
- Service-level metrics (fill rates, instrument availability)
Counterarguments
- Peers also have sizable field teams; differentiation depends on execution
Technology & Data, Bone Cement and Surgical
Orthopedic surgical robotics and navigation, digital care pathways/analytics, bone cement, and surgical instruments
Revenue share computed from Q1 2026 Form 10-Q product-category table: Technology & Data, Bone Cement and Surgical net sales $171.8M / $2.087B total.
Insufficient segment-specific evidence to assign a moat claim.
Evidence
We invest a significant amount of time and expense in training sales associates...
Supports qualification/training intensity and workflow reliance around product-specific usage.
Consignment sales represented approximately 85 percent of our net sales in 2025.
Consignment plus local inventory/rep coverage increases service levels and raises the operational cost of switching vendors.
Zimmer Biomet led... the knee... market with 30.1%... share...
Directly states 2023 worldwide knee implant share for Zimmer Biomet.
Sales force representatives must have strong technical selling and medical education skills...
Highlights the technical/clinical support needed around product usage in procedures.
We utilize a network of sales associates, sales managers and support personnel...
Supports the existence of a broad service/sales footprint that is difficult for smaller entrants to replicate.
Showing 5 of 7 sources.
Risks & Indicators
Erosion risks
- Hospital standardization reduces surgeon choice
- New implant designs narrow differentiation
- Shift of volume to price-sensitive ambulatory surgery centers
- Distributor/channel disruption
- ERP/logistics execution issues
- Hospital consolidation reduces the value of local density
Leading indicators
- Knee share trend vs SYK/JNJ/SNN
- Pricing realization (net price/mix)
- Adoption rates of new knee platforms and robotics-assisted procedures
- Backorder/fill-rate metrics
- Rep productivity and churn
- Customer complaint / service levels
Research ZBH elsewhere
Keep the research going
More Rankings & Systems
Quality Stocks
High quality stocks ranked by profitability, margins, free cash flow quality, durability, solvency, and accounting...
Stock rankingUndervalued Stocks
Undervalued stocks from the NA & Europe universe, ranked with a multi-measure value system and quality controls.
Stock rankingDividend Stocks
Dividend stocks ranked by payout yield, payout sustainability, dividend growth, quality, balance-sheet safety, risk...
Stock rankingDefensive Stocks
Defensive stocks ranked by low volatility, low beta, intermediate momentum, durable profitability, balance sheet...
Stock rankingMomentum Stocks
Momentum stocks ranked by total return momentum, relative momentum, trend confirmation, and risk-adjusted momentum...
Stock rankingConviction 10
A concentrated 10-stock strategy from the NA & Europe universe, ranked across quality, value, growth, momentum, and...
Curation & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.